Li Jerry

5PUBLICATIONS

26CO-AUTHORS

Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|May 12, 2026

Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid Tumors.

|Apr 20, 2026

First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer.

|Oct 23, 2025

Application of Machine Learning for Predicting Progression-Free and Overall Survival in Patients With Renal Cell Carcinoma.

Caroline W Grant, Jerry Li, Swan Lin

|Jun 13, 2024

Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.

Li Jerry, Lin Swan, Nickens Dana

|May 03, 2021

The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants.

Jerry Li, Yazdi K Pithavala, Jason Gong

Pageof 1

Frequent Collaborators

Yazdi K Pithavala

Josué Kunjom Mfopou

Joseph Chen

Caroline W Grant

Swan Lin

Daniele Ouellet

Mohamed H Shahin

Solange Peters

Sarina A Piha-Paul

Kartik Sehgal

Frequent Collaborators

Yazdi K Pithavala

Josué Kunjom Mfopou

Joseph Chen

Caroline W Grant